Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 2001 Jul;47:1425–1430.

Pap test results. Responding to Bethesda system reports.

T J Colgan 1
PMCID: PMC2018540  PMID: 11494930

Abstract

OBJECTIVE: To review the adequacy and diagnostic categories of the Bethesda system for reporting Pap test results (cervicovaginal cytology) and summarize management options. QUALITY OF EVIDENCE: The latest research evidence and guidelines from both international and Canadian sources are reviewed. With a few exceptions, good evidence supports particular management approaches for each adequacy statement and diagnostic category. MAIN MESSAGE: Women with unsatisfactory Pap smears should be re-examined and retested. Women with satisfactory smears and a diagnosis of "within normal limits" (WNL) or "benign cellular changes" (BCC) should be retested only at recommended screening intervals. Women with "satisfactory but limited by..." results and a diagnosis of WNL or BCC should have individualized follow up. Women with diagnoses of high-grade squamous intraepithelial lesions, atypical glandular cells of uncertain significance, or malignancy should have further investigation (colposcopy). Optimal management of asymptomatic women with normal cervices and reports of atypical squamous cells of uncertain significance or low-grade squamous intraepithelial lesions is still controversial. CONCLUSION: Management of women following Pap tests is determined by both the adequacy of the test and diagnoses based on the results.

Full Text

The Full Text of this article is available as a PDF (163.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson G. H., Benedet J. L., Le Riche J. C., Matisic J. P., Thompson J. E. Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol. 1992 Jul;80(1):1–4. doi: 10.3109/01443619209029905. [DOI] [PubMed] [Google Scholar]
  2. Benoit A. G., Krepart G. V., Lotocki R. J. Results of prior cytologic screening in patients with a diagnosis of Stage I carcinoma of the cervix. Am J Obstet Gynecol. 1984 Mar 1;148(5):690–694. doi: 10.1016/0002-9378(84)90775-0. [DOI] [PubMed] [Google Scholar]
  3. Cannistra S. A., Niloff J. M. Cancer of the uterine cervix. N Engl J Med. 1996 Apr 18;334(16):1030–1038. doi: 10.1056/NEJM199604183341606. [DOI] [PubMed] [Google Scholar]
  4. Carmichael J. A., Jeffrey J. F., Steele H. D., Ohlke I. D. The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol. 1984 Mar 1;148(5):685–690. doi: 10.1016/0002-9378(84)90774-9. [DOI] [PubMed] [Google Scholar]
  5. Cox J. T. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings. JAMA. 1999 May 5;281(17):1645–1647. doi: 10.1001/jama.281.17.1645. [DOI] [PubMed] [Google Scholar]
  6. Cuzick J. Human papillomavirus testing for primary cervical cancer screening. JAMA. 2000 Jan 5;283(1):108–109. doi: 10.1001/jama.283.1.108. [DOI] [PubMed] [Google Scholar]
  7. Davey D. D., Nielsen M. L., Naryshkin S., Robb J. A., Cohen T., Kline T. S. Atypical squamous cells of undetermined significance. Current laboratory practices of participants in the College of American Pathologists Interlaboratory. Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 1996 May;120(5):440–444. [PubMed] [Google Scholar]
  8. Hankins C. A., Lamont J. A., Handley M. A. Cervicovaginal screening in women with HIV infection: a need for increased vigilance? CMAJ. 1994 Mar 1;150(5):681–686. [PMC free article] [PubMed] [Google Scholar]
  9. Ho G. Y., Bierman R., Beardsley L., Chang C. J., Burk R. D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998 Feb 12;338(7):423–428. doi: 10.1056/NEJM199802123380703. [DOI] [PubMed] [Google Scholar]
  10. Johnson K. Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination. CMAJ. 1995 Feb 15;152(4):483–493. [PMC free article] [PubMed] [Google Scholar]
  11. Jones B. A., Novis D. A. Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996 Jun;120(6):523–531. [PubMed] [Google Scholar]
  12. Kurman R. J., Henson D. E., Herbst A. L., Noller K. L., Schiffman M. H. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 1994 Jun 15;271(23):1866–1869. [PubMed] [Google Scholar]
  13. Manos M. M., Kinney W. K., Hurley L. B., Sherman M. E., Shieh-Ngai J., Kurman R. J., Ransley J. E., Fetterman B. J., Hartinger J. S., McIntosh K. M. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999 May 5;281(17):1605–1610. doi: 10.1001/jama.281.17.1605. [DOI] [PubMed] [Google Scholar]
  14. Marshall K. G. Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm. CMAJ. 1996 Jul 15;155(2):169–176. [PMC free article] [PubMed] [Google Scholar]
  15. Miller A. B., Anderson G., Brisson J., Laidlaw J., Le Pitre N., Malcolmson P., Mirwaldt P., Stuart G., Sullivan W. Report of a National Workshop on Screening for Cancer of the Cervix. CMAJ. 1991 Nov 15;145(10):1301–1325. [PMC free article] [PubMed] [Google Scholar]
  16. Mintzer M., Curtis P., Resnick J. C., Morrell D. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities. Cancer. 1999 Jun 25;87(3):113–117. [PubMed] [Google Scholar]
  17. Nasiell K., Roger V., Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol. 1986 May;67(5):665–669. doi: 10.1097/00006250-198605000-00012. [DOI] [PubMed] [Google Scholar]
  18. Parboosingh E. J., Anderson G., Clarke E. A., Inhaber S., Kaegi E., Mills C., Mao Y., Root L., Stuart G., Stachenko S. Cervical cancer screening: are the 1989 recommendations still valid? National Workshop on Screening for Cancer of the Cervix. CMAJ. 1996 Jun 15;154(12):1847–1853. [PMC free article] [PubMed] [Google Scholar]
  19. Schiffman M., Herrero R., Hildesheim A., Sherman M. E., Bratti M., Wacholder S., Alfaro M., Hutchinson M., Morales J., Greenberg M. D. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA. 2000 Jan 5;283(1):87–93. doi: 10.1001/jama.283.1.87. [DOI] [PubMed] [Google Scholar]
  20. Sherman M. E., Schiffman M. H., Strickler H., Hildesheim A. Prospects for a prophylactic HPV vaccine: rationale and future implications for cervical cancer screening. Diagn Cytopathol. 1998 Jan;18(1):5–9. doi: 10.1002/(sici)1097-0339(199801)18:1<5::aid-dc2>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  21. Sherman M. E., Tabbara S. O., Scott D. R., Kurman R. J., Glass A. G., Manos M. M., Burk R. D., Rush B. B., Schiffman M. "ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol. 1999 Apr;12(4):335–342. [PubMed] [Google Scholar]
  22. Stewart D. E., Lickrish G. M., Sierra S., Parkin H. The effect of educational brochures on knowledge and emotional distress in women with abnormal Papanicolaou smears. Obstet Gynecol. 1993 Feb;81(2):280–282. [PubMed] [Google Scholar]
  23. Stoler M. H. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol. 2000 Jan;19(1):16–28. doi: 10.1097/00004347-200001000-00004. [DOI] [PubMed] [Google Scholar]
  24. Stuart G. C., McGregor S. E., Duggan M. A., Nation J. G. Review of the screening history of Alberta women with invasive cervical cancer. CMAJ. 1997 Sep 1;157(5):513–519. [PMC free article] [PubMed] [Google Scholar]
  25. Wright T. C., Jr, Denny L., Kuhn L., Pollack A., Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000 Jan 5;283(1):81–86. doi: 10.1001/jama.283.1.81. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES